These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 7040558)
1. An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement. Gammon WR; Merritt CC; Lewis DM; Sams WM; Carlo JR; Wheeler CE J Invest Dermatol; 1982 Apr; 78(4):285-90. PubMed ID: 7040558 [TBL] [Abstract][Full Text] [Related]
2. Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin. Gammon WR; Lewis DM; Carlo JR; Sams WM; Wheeler CE J Invest Dermatol; 1980 Oct; 75(4):334-9. PubMed ID: 7000926 [TBL] [Abstract][Full Text] [Related]
3. Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid. Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo JR J Invest Dermatol; 1982 Jan; 78(1):52-7. PubMed ID: 7033396 [TBL] [Abstract][Full Text] [Related]
4. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods. Gammon WR; Inman AO; Wheeler CE J Invest Dermatol; 1984 Jul; 83(1):57-61. PubMed ID: 6376640 [TBL] [Abstract][Full Text] [Related]
5. Induction of leukocyte adherence at the basement membrane zone with subsequent activation of their metabolic pathway by pemphigoid antibodies and complement. Iwatsuki K; Tagami H; Yamada M Acta Derm Venereol; 1983; 63(4):290-5. PubMed ID: 6195859 [TBL] [Abstract][Full Text] [Related]
6. Deposition of the membrane attack complex of complement in bullous pemphigoid. Dahl MV; Falk RJ; Carpenter R; Michael AF J Invest Dermatol; 1984 Feb; 82(2):132-5. PubMed ID: 6363566 [TBL] [Abstract][Full Text] [Related]
7. A functional assay for complement-activating antibodies to the cutaneous basement membrane zone. Gammon WR; Merritt CC Ann N Y Acad Sci; 1983; 420():335-42. PubMed ID: 6372599 [No Abstract] [Full Text] [Related]
8. Mechanism of lesion production in pemphigus and pemphigoid. Sams WM; Gammon WR J Am Acad Dermatol; 1982 Apr; 6(4 Pt 1):431-52. PubMed ID: 7042774 [TBL] [Abstract][Full Text] [Related]
9. Linear immunofluorescence staining of the cutaneous basement membrane zone produced by pemphigoid antibodies: the result of hemidesmosome staining. Mutasim DF; Anhalt GJ; Diaz LA; Patel HP J Am Acad Dermatol; 1987 Jan; 16(1 Pt 1):75-82. PubMed ID: 2433316 [TBL] [Abstract][Full Text] [Related]
10. Identification of a novel basement membrane antigen (p84) defined by sera with antibodies to both the epidermal and dermal side of split skin. Gao SQ; Bystryn JC J Invest Dermatol; 1994 Feb; 102(2):236-40. PubMed ID: 8106753 [TBL] [Abstract][Full Text] [Related]
11. Ultrastructural localization of in vitro binding sites of circulating anti-basement membrane zone antibodies in bullous pemphigoid. Yamasaki Y; Nishikawa T Acta Derm Venereol; 1983; 63(6):501-6. PubMed ID: 6198839 [TBL] [Abstract][Full Text] [Related]
12. Correlation of serum anti-basement membrane zone antibody and malignancy in bullous pemphigoid. Ahmed AR; Amerian ML Dermatologica; 1985; 171(2):82-5. PubMed ID: 3899759 [TBL] [Abstract][Full Text] [Related]
13. Localized pemphigoid: a case report showing in situ deposition as well as presence in serum of IgG and IgA anti-basement membrane zone antibodies. Sugihara K; Dekio S; Tohgi K; Jidoi J J Dermatol; 1987 Feb; 14(1):73-6. PubMed ID: 3301954 [No Abstract] [Full Text] [Related]
14. The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid. Kelly SE; Wojnarowska F Br J Dermatol; 1988 Jan; 118(1):31-40. PubMed ID: 3277659 [TBL] [Abstract][Full Text] [Related]
15. Optimal conditions of 1 M NaCl splitting technique to demonstrate basement membrane zone antigens in bullous pemphigoid, epidermolysis bullosa acquisita and linear IgA bullous dermatoses. Jenkins RE; Rodenas J; Bhogal BS; Black MM Dermatology; 1994; 189 Suppl 1():133-4. PubMed ID: 8049556 [TBL] [Abstract][Full Text] [Related]
16. Leukocyte chemotaxis to the dermal-epidermal junction of human skin mediated by pemphigoid antibody and complement: mechanism of cell attachment in the in vitro leukocyte attachment method. Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo J J Invest Dermatol; 1981 Jun; 76(6):514-22. PubMed ID: 7017015 [No Abstract] [Full Text] [Related]
17. Basement membrane reactivity of antisera to type IV collagen and sera from patients with bullous pemphigoid and epidermolysis bullosa acquisita. Peng TK; Nisengard RJ; Levine MJ; Beutner EH Proc Natl Sci Counc Repub China B; 1984 Jul; 8(3):268-73. PubMed ID: 6400590 [TBL] [Abstract][Full Text] [Related]
18. Production of anti-basement membrane-zone antibody by peripheral blood leukocytes of pemphigoid patients. Ahmed AR; Stevens RH; Saxon A J Clin Immunol; 1982 Jul; 2(3):179-85. PubMed ID: 6811607 [TBL] [Abstract][Full Text] [Related]
19. Papules with basement membrane zone antibodies preceding bullous pemphigoid. Lorette G; Fetissoff F Arch Dermatol; 1982 Nov; 118(11):878-9. PubMed ID: 6753763 [No Abstract] [Full Text] [Related]
20. Serum from normal elderly individuals contains anti-basement membrane zone antibodies. Hachisuka H; Kurose K; Karashima T; Mori O; Maeyama Y Arch Dermatol; 1996 Oct; 132(10):1201-5. PubMed ID: 8859031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]